Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteins

作者: Charles D. Smith , Jack T. Zilfou , Xinqun Zhang , Gary R. Hudes , Kenneth D. Tew

DOI: 10.1002/1097-0142(19950515)75:10<2597::AID-CNCR2820751030>3.0.CO;2-R

关键词: VinblastineAlbuminVerapamilPaclitaxelMedicineP-glycoproteinInternal medicineIn vivoBlood proteinsEstramustineEndocrinologyCancer researchOncology

摘要: Background. Estramustine previously has been shown to interact with P-glycoprotein and restore intracellular accumulation of vinblastine paclitaxel in cells overexpressing this drug transporter. However, the ability estramustine potentiate cytotoxicities several drugs was less than that expected. To resolve apparent discordance, authors examined effects serum on actions estramustine. Methods. The anticancer or without verapamil toward MCF-7 breast carcinoma a P-glycoprotein-overexpressing subline MCF-7/ADR were determined using sulforhodamine-binding assay. extent [ 3 H]vinblastine H]paclitaxel for each standard methods, binding radiolabeled plasma proteins characterized by equilibrium dialysis. Results. Without serum, sensitivities P-glycoprotein-transported increased verapamil. Conversely, when treated 10% these verapamil, but not markedly ; however, suppressed much more strongly those Equilibrium dialysis experiments demonstrated H]estramustine binds proteins, predominantly albumin, whereas albumin alpha 1 -acid-glycoprotein, alpha-acid-glycoprotein. Conclusion. Although can bind P-glycoprotein, its effectiveness as reversing agent vivo likely is limited proteins. Cancer 1995 ;75 :2597-2604.

参考文章(32)
Kathleen M. Giacomini, Fee Mi Wong, Thomas N. Tozer, Correction for Volume Shift during Equilibrium Dialysis by Measurement of Protein Concentration. Pharmaceutical Research. ,vol. 1, pp. 179- 181 ,(1984) , 10.1023/A:1016352725805
Tew Kd, The mechanism of action of estramustine. Seminars in Oncology. ,vol. 10, pp. 21- ,(1983)
Awtar Krishan, Guan Chen, Cheppail Ramachandran, Thaliblastine, a Plant Alkaloid, Circumvents Multidrug Resistance by Direct Binding to P-Glycoprotein Cancer Research. ,vol. 53, pp. 2544- 2547 ,(1993)
Björn Dahllöf, Fernando Cabral, Anita Billström, Beryl Hartley-Asp, Estramustine depolymerizes microtubules by binding to tubulin Cancer Research. ,vol. 53, pp. 4573- 4581 ,(1993)
Gilles Klopman, Raquel F. Epand, Richard M. Epand, Nadeem Ahmed, Istvan Kolossvary, Sanjay Srivastava, Structure-Activity Study and Design of Multidrug-resistant Reversal Compounds by a Computer Automated Structure Evaluation Methodology Cancer Research. ,vol. 52, pp. 4121- 4129 ,(1992)
Shun-Ichi Ikeda, Masanori Sugita, Akihiko Yoshimura, Tomoyuki Sumizawa, Haruhiko Douzono, Yukihiro Nagata, Shin-Ichi Akiyama, Aspergillus species strain m39 produces two naphtho-γ-pyrones that reverse drug resistance in human KB cells International Journal of Cancer. ,vol. 45, pp. 508- 513 ,(1990) , 10.1002/IJC.2910450323
H. L. Pearce, A. R. Safa, N. J. Bach, M. A. Winter, M. C. Cirtain, W. T. Beck, Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance Proceedings of the National Academy of Sciences of the United States of America. ,vol. 86, pp. 5128- 5132 ,(1989) , 10.1073/PNAS.86.13.5128
Nogae Ichiro, Kohno Kimitoshi, Kikuchi Junko, kuwano Michihiko, Akiyama Shin-Ichi, Kiue Akira, Suzuki Ken-Ichi, Yoshida Yohji, Marilyn M. Cornwell, Ira Pastan, Michael M. Gottesman, Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labeling of P-glycoprotein Biochemical Pharmacology. ,vol. 38, pp. 519- 527 ,(1989) , 10.1016/0006-2952(89)90393-6
L. J. Goldstein, H. Galski, A. Fojo, M. Willingham, S.-L. Lai, A. Gazdar, R. Pirker, A. Green, W. Crist, G. M. Brodeur, M. Lieber, J. Cossman, M. M. Gottesman, I. Pastan, Expression of Multidrug Resistance Gene in Human Cancers Journal of the National Cancer Institute. ,vol. 81, pp. 116- 124 ,(1989) , 10.1093/JNCI/81.2.116